Latest Pharmaceuticals Tenders
Showing top 10 of 38Germany – Pharmaceutical products – Open-House-Biologika-Rabatverträge 2025-35 - Natalizumab (Darreichungsform zur intra
Die beteiligten Kassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Natalizumab (Darreichungsform zur intravenösen An...
CLOSED
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneim
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing th...
CLOSED
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den gena
Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredi...
CLOSED
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Botulinumtoxin Typ A, Fertigarzneimittelbezeic
Germany – Pharmaceutical products – Open house drug discount contracts Botulinum toxin type A, finished medicinal product name Xeomin(R), ATC M03AX21...
CLOSED
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Brinzolamid und Brimonidin, ATC S01EC24
Germany – Pharmaceutical products – Open house drug rebate contracts Brinzolamide and Brimonidine, ATC S01EC24...
CLOSED
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wir
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient carglumic ...
CLOSED
Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Sections 130a para. 8/13
Die AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse bietet allen interessierten pharmazeutischen Unternehmen ohne Auswahlentscheidung Rabattverträge mit dem Wirkstoff Fentanyl, nur Sublingualtable...
CLOSED
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Tiaprid (ATC: N05AL03)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Tiaprid (ATC: N05AL03)...
CLOSED
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu
Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Sections 130a para. 8/130c para. 1 SGB V for medicinal products containing the active ingredient iron(II...
CLOSED
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege e
Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V), by way of an open-house model ...
CLOSED